Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Glycogenin 1 Antikörper (AA 251-350) (Cy5)

GYG1 Reaktivität: Human IF (cc), IF (p) Wirt: Kaninchen Polyclonal Cy5
Produktnummer ABIN1704673
  • Target Alle Glycogenin 1 (GYG1) Antikörper anzeigen
    Glycogenin 1 (GYG1)
    Bindungsspezifität
    • 16
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 251-350
    Reaktivität
    • 28
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 23
    • 5
    Kaninchen
    Klonalität
    • 25
    • 3
    Polyklonal
    Konjugat
    • 14
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Glycogenin 1 Antikörper ist konjugiert mit Cy5
    Applikation
    • 27
    • 14
    • 14
    • 10
    • 7
    • 4
    • 2
    • 1
    • 1
    Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Dog,Cow,Sheep
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human Glycogenin 1
    Isotyp
    IgG
    Top Product
    Discover our top product GYG1 Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    Glycogenin 1 (GYG1)
    Andere Bezeichnung
    Glycogenin 1 (GYG1 Produkte)
    Synonyme
    GSD15 antikoerper, GYG antikoerper, Gyg antikoerper, gyg antikoerper, fc13d04 antikoerper, fi23f07 antikoerper, gyg1 antikoerper, wu:fc13d04 antikoerper, wu:fi23f07 antikoerper, zgc:55385 antikoerper, zgc:85619 antikoerper, glycogenin-1 antikoerper, MGC79098 antikoerper, GYG1 antikoerper, glycogenin 1 antikoerper, glycogenin 1a antikoerper, glycogenin 1 S homeolog antikoerper, GYG1 antikoerper, Gyg1 antikoerper, gyg1 antikoerper, gyg1a antikoerper, gyg1.S antikoerper
    Hintergrund

    Synonyms: Glycogenin, Glycogenin-1, Glycogenin1, GLYG_HUMAN, GN-1, GN1, GYG 1, GYG, GYG1.

    Background: Glycogen synthesis is initiated by the autoglucosylation of Glycogenin-1. Specifically, Glycogenin-1 glucosylates itself to begin the synthesis of glycogen in mammalian skeletal muscle. It acts as the primer to which further glucose monomers may be added. All of the Glycogenin-1 Molecules contain at least one glucosyl residue before autoglucosylation begins. The first step of the glycogen synthesis occurs when a glucose molecule from UDP-glucose binds to the hydroxyl group of Tyr 194 on the Glycogenin-1 Molecule. Using its glucosyltransferase activity, Glycogenin-1 adds more glucoses, each one coming from UDP-glucose. The glycosylation process reaches a plateau when five new glucose residues have been added, at which point glycogen synthase (GS) takes over and further elongates the chain. Glycogenin-1 remains covalently attached to the reducing end of the glycogen molecule.

    Pathways
    Cellular Glucan Metabolic Process
Sie sind hier:
Kundenservice